# clm_96E0C48FCE1B

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_net_income  
value: 79,720,000 United States dollar  
valid_from: 2014-09-30  
valid_to: 2015-03-31  
published: 2014-11-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_372DCD80253C  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly net income: 79,720,000 United States dollar", as of 2014-09-30 (until 2015-03-31). Claim clm_96E0C48FCE1B, https://asof.is/claim/clm_96E0C48FCE1B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217614000046/0001532176-14-000046-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q3 FY2014, filed 2014-11-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217614000046/0001532176-14-000046-index.htm (primary, SEC EDGAR 10-Q Q3 FY2014, published 2014-11-04)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 92,735,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_96E0C48FCE1B](/claim/clm_96E0C48FCE1B.md) | [clm_D170703CFE06](/claim/clm_D170703CFE06.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.